Cargando…
Inflammatory cytokines and aromatase inhibitor-associated musculoskeletal syndrome: a case–control study
BACKGROUND: The aromatase inhibitor (AI)-associated musculoskeletal syndrome (AIMSS) occurs in approximately 50% of AI-treated patients. Inflammatory mediators are associated with oestrogen signalling and may change with oestrogen depletion. We hypothesised that AIMSS may be associated with changes...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2920022/ https://www.ncbi.nlm.nih.gov/pubmed/20606683 http://dx.doi.org/10.1038/sj.bjc.6605768 |